Daniel Pelliccia

RepRisk AG is an independent research firm headquartered in Zurich, Switzerland. The firm was founded in 1998 and provides ESG research in 20 major business languages that can be used for rigorous back-testing and quantitative analysis.

Inspirit IoT, Inc. delivers general-purpose High-Level Synthesis (HLS) with a focus on Machine-Learning and FPGA-based accelerators for IoT devices, cloud vendors and data centers. The company is headquartered in Champaign, IL.

R3i Ventures Pte Ltd (R3i Ventures) is a venture capital firm founded in 2016. The firm is headquartered in Singapore.

StratifiCare is a Singaporean company that specializes in the development and manufacturing of IVD assay solutions for personalized medicine. The company is based in Singapore, SG, and has subsidiaries in the United States. With over 50 years of cumulative experience in Biomedical R&D and technology commercialization, StratifiCare is working on a new Point-of-Care Platform to transform the way patients are managed through personalized care. The company was founded in 2015 with the aim of empowering personalized medicine through innovative diagnostic solutions. Anthony Chua founded the company in 2015 and has been the CEO since then.

Raiven Capital (Raiven Capital) is a venture capital firm founded in 2018 by Paul Dugsin and Supreet Manchanda. The firm is headquartered in Toronto, Canada.

MGA Thermal Pty Ltd. is an Australian clean energy company that specializes in energy storage. The company is based in Tomago, Australia. The company's breakthrough technology involves the use of mga blocks that store and deliver thermal energy while remaining solid. This technology is crucial for grid decarbonisation and allows renewable energy to be turned into green steam and power that is available at any time of the day. The CEO of the company is Erich Kisi.

Viewmind, Inc. is a digital health and artificial intelligence company based in an undisclosed location. The American company provides clinically validated solutions for the early diagnosis of cognitive diseases. Viewmind has developed a unique, reliable, non-invasive, affordable, and accessible digital biomarker technology that delivers clinical results as accurate as today's definitive tests and is viable for early screening at scale. Viewmind's diagnostic solutions analyze eye movement patterns, which is considered cognitive health data in its purest form. The company's tools can unlock cognitive potential and achieve extraordinary mental breakthroughs. Viewmind's comprehensive research delves into the scientific principles behind cognitive enhancement. The company was founded by Matias Shulz, Gerardo Fernandez, and Mark Edwards, with Mark Edwards serving as the CEO since incorporation.

SIA Longenesis promotes collaboration between biomedical institutions, patient organizations, and research partners. The company is based in Riga, Latvia and has subsidiaries in Hong Kong. The Latvian company identifies biomedical data from metadata files, onboards population cohorts, and engages new patients in research. The company was founded by Garri Zmudze.